Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 04, 2022

BUY
$19.63 - $26.62 $1.12 Million - $1.52 Million
56,994 Added 275.32%
77,695 $1.53 Million
Q1 2022

May 11, 2022

SELL
$24.65 - $29.0 $869,750 - $1.02 Million
-35,284 Reduced 63.02%
20,701 $540,000
Q4 2021

Feb 14, 2022

BUY
$27.74 - $34.09 $1.55 Million - $1.91 Million
55,985 New
55,985 $1.59 Million
Q3 2021

Nov 15, 2021

SELL
$29.2 - $36.72 $3.26 Million - $4.1 Million
-111,560 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$28.76 - $35.98 $3.21 Million - $4.01 Million
111,560 New
111,560 $3.87 Million
Q1 2020

May 14, 2020

SELL
$16.68 - $32.25 $1.48 Million - $2.86 Million
-88,631 Closed
0 $0
Q4 2019

Feb 13, 2020

SELL
$25.29 - $29.45 $5.01 Million - $5.83 Million
-198,000 Reduced 69.08%
88,631 $2.61 Million
Q3 2019

Nov 14, 2019

BUY
$25.62 - $34.96 $5.51 Million - $7.52 Million
215,200 Added 301.27%
286,631 $7.62 Million
Q2 2019

Aug 12, 2019

SELL
$31.11 - $34.79 $10.1 Million - $11.3 Million
-324,439 Reduced 81.96%
71,431 $2.41 Million
Q1 2019

May 15, 2019

BUY
$29.0 - $32.83 $11.5 Million - $13 Million
395,870 New
395,870 $12.7 Million

Others Institutions Holding ELAN

About Elanco Animal Health Inc


  • Ticker ELAN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 474,113,984
  • Market Cap $5.42B
  • Description
  • Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...
More about ELAN
Track This Portfolio

Track Seven Eight Capital, LP Portfolio

Follow Seven Eight Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Seven Eight Capital, LP with notifications on news.